Biology of Blood and Marrow Transplantation
Volume 15, Issue 2 , Pages 183-194 , February 2009

Activated Notch Supports Development of Cytokine Producing NK Cells Which Are Hyporesponsive and Fail to Acquire NK Cell Effector Functions

Received 4 August 2008 ,Accepted 20 November 2008.

References 

  1. Lanier LL, Corliss B, Phillips JH. Arousal and inhibition of human NK cells. Immunol Rev. 1997;155:145–154
  2. Blom B, Spits H. Development of human lymphoid cells. Annu Rev Immunol. 2006;24:287–320
  3. Miller JS, McCullar V. Human natural killer cells with polyclonal lectin and immunoglobulin-like receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIRL2/L3/S2. Blood. 2001;98:705–713
  4. Parham P. Talking license with natural killer cell maturation and repertoire development. Immun Rev. 2006;214:155–160
  5. Cooley S, Xiao F, Pitt M, et al. 2007. A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self MHC is developmentally immature. Blood. 2007;110:578–586
  6. Cooper MA, Fehniger TA, Turner SC, et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset. Blood. 2001;97:3146–3151
  7. Frey M, Packianathan NB, Fehniger TA, et al. Differential expression and function of L-selectine on CD56bright and CD56dim natural killer cell subsets. J Immunol. 1998;161:400–408
  8. Freud AG, Becknell B, Roychowdhury S, et al. 2005. A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells. Immunity. 2005;22:295–304
  9. Nguyen S, Dhedin N, Vernant JP, et al. NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect. Blood. 2005;105:4135–4142
  10. Shilling HG, McQueen KL, Cheng NW, et al. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Blood. 2003;101:3730–3740
  11. Cooley S, McCullar V, Wangen R, et al. KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation. Blood. 2005;106:4370–4376
  12. Miller JS, Alley KA, McGlave P. Differentiation of natural killer (NK) cells from human primitive marrow progenitors in stroma-based long-term culture system: identification of CD34+CD7+ NK progenitor. Blood. 1994;83:2594–2601
  13. Mrozek E, Anderson P, Caligiuri MA. Role of interleukin 15 in the development of human CD56+ natural killer cells from CD34+ hematopoetic progenitor cells. Blood. 1996;87:2632–2640
  14. Lotzova E, Savary CA, Champlin RE. Genesis of human oncolytic natural killer cells from primitive CD34+CD33− bone marrow progenitors. J Immunol. 1993;150:5263–5269
  15. Miller JS, Verfaille C, McGlave P. The generation of natural killer cells from CD34+/DR− primitive progenitors in human long-term bone marrow culture. Blood. 1992;80:2182–2187
  16. Hackett J, Bennett M, Kumar V. Origin and differentiation of natural killer cells. Characteristics of transplantable NK cell precursor. J Immunol. 1985;134:3731–3738
  17. Miller JS, McCullar V, Punzel M, Lemischka IR, Moore KA. Single adult human CD34(+)/Lin−/CD38(−) progenitors give rise to natural killer cells, B-lineage cells, dendritic cells, and myeloid cells. Blood. 1999;93:96–106
  18. McCullar V, Oostendorp R, Panoskaltsis-Mortari A, et al. Mouse fetal and embryonic liver cells differentiate human umbilical cord blood progenitors into CD56-negative natural killer cell precursors in the absence of interleukin-15. Exp Hematol. 2008;36:598–608
  19. Stier S, Cheng T, Dombkowski D, Carlesso N, Scadden DT. Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage commitment. J Exp Med. 2000;192:1775–1784
  20. Varnum-Finney B, Brashem-Stein C, Bernstein ID. Combined effects of Notch signaling and cytokines induce a multiple log increase in precursors with lymphoid and myeloid reconstituting ability. Blood. 2003;101:1784–1789
  21. Jaleco AC, Neves H, Hooijberg E, et al. 2001. Differential effect of Notch ligands Delta-1 and Jagged-1 in human lymphoid differentiation. J Exp Med. 2001;194:991–1001
  22. De Smedt M, Taghon T, Van de Walle I, DeSmet G, leclercq G, Plum J. Notch signaling induced cytoplasmic CD3ε expression in human differentiating NK cells. Blood. 2007;110:2696–2703
  23. Carotaa S, Brady J, Wu Li, Nutt SE. Transient Notch signaling induces NK cells potential in Pax5-deficient pro-B cells. Eur J Immunol. 2006;36:1–11
  24. Varnum-Finney B, Purton LE, Yu M, et al. The Notch ligand, Jagged 1, influence the development of primitive hematopoietic precursor cells. Blood. 1998;91:4084–4091
  25. Radtke F, Wilson A, Ernst B, McDonald HR. The role of Notch signaling during hematopoetic lineage commitment. Immunol Rev. 2002;187:65–74
  26. Garcia-Peydro M, de Yebenes VG, Toribio ML. Sustained Notch 1 signaling instructs the earliest human intrathymic precursors to adopt a γδ T cell fate in human fetal thymus organ culture. Blood. 2003;102:2444–2451
  27. Bray S, Furrols M. Notch pathway: making sense of suppressor of hairless. Curr Biol. 2001;11:R217–R221
  28. Aster JC, Xu L, Karnell FG, Patriub V, Pui JC, Pear WS. Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by notch1. Mol Cell Biol. 2000;20:7505–7515
  29. Naviaux RK, Costanzi E, Haas M, Verma IM. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J Virol. 1996;70:5701–5705
  30. Chiorean EG, Dylla SJ, Olsen K, Lenvik T, Soignier Y, Miller JS. BCR/ABL alters the function of NK cells and the aqcuisition of killer immunoglobulin-like receptors (KIR). Blood. 2003;101:3527–3533
  31. Pierson BA, Miller JS. CD56+bright and CD56+dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis. Blood. 1996;88:2279–2287
  32. Grzywacz B, Kataria N, Sikora M, et al. Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells. Blood. 2006;108:3824–3833
  33. Freud AG, Yokohama A, Becknell B, et al. Evidence for discrete stages of human natural killer cell differentiation in vivo. J Exp Med. 2006;203:1033–1043
  34. Smyth MJ, Cretney E, Kelly JM, et al. Activation of NK cell cytotoxicity. Mol Immunol. 2001;42:501–510
  35. Cooper MA, Fehniger TA, Caliguiri MA. The biology of human killer subset. Trends Immunol. 2001;22:633–640
  36. Loza MJ, Zamai L, Zamai L, Azzoni L, Rosati E, Perussia B. Expression of type 1 (IFNγ)and type 2 (IL-13, IL-5) cytokines at distinct stages of NK cell differentiation from progenitor cells. Blood. 2002;99:1273–1281
  37. Wendt K, Wild E, Buyny S, Buer J, Schmidt RE, Jacobs R. 2006. Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells. J Leukoc Biol. 2006;80:1529–1541
  38. Ferlazzo G, Thomas D, Lin SL, et al. 2004. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol. 2004;172:1455–1462
  39. Aoyama K, Delaney C, Varnum-Finney B, Kohn AD, Moon RT, Bernstein ID. The interaction of the Wnt and Notch pathways modulates natural killer versus T cell differentiation. Stem Cells. 2007;25:2488–2497
  40. Vosshenrich CA, Garcia-Ojeda ME, Samson Villeger SE. A thymic pathway of mouse natural killer cell development is characterized by expression of GATA-3 and CD127. Nat Immunol. 2006;7:1217–1224
  41. Di Santo JP, Vosshenrich CA. Bone marrow versus thymic pathways of natural killer cell development. Immunol Rev. 2006;214:35–46
  42. Sander GR, Powell BC. Expression of notch receptors and ligands in the adult gut. J Histochem Cytochem. 2004;52:509–516
  43. Parham P. Talking license with natural killer cell maturation and repertoire development. Immun Rev. 2006;214:155–160
  44. De Smedt M, Hoebeke I, Reynvoet K, Leclercq G, Plum J. Different thresholds of Notch signaling bias human precursor cells toward B-, NK-, monocytic/dendritic, or T-cell lineage in thymus microenvironment. Blood. 2005;106:3498–3506
  45. Rothenberg EV, Diamond RA, Pepper KA, Yang JA. 1990. IL-2 Gene inducibility in T cells before T cell receptor expression. Changes in signaling pathways and gene expression requirements during intrathymic maturation. J Immunol. 1990;144:1614–1624
  46. Ohishi K, Varnum-Finney B, Bernstein ID. Delta-1 enhances marrow and thymus repopulating ability of human CD34+CD38− cord blood cells. J Clin Invest. 2002;110:1165–1174
  47. Ohishi O, Varnum-Finney B, Serda RE, Anasetti C, Bernstein ID. The Notch ligand, Delta-1, inhibits the differentiation of monocytes into macrophages but permits their differentiation into dendritic cells. Blood. 2001;98:1402–1407
  48. La Motte-Mohs RN, Herer E, Zuniga-Pflucker JC. Induction of T cell development from human cord blood hematopoetic stem cells by Delta-like 1 in vitro. Blood. 2005;105:1432–1439
  49. Lynch L, O'Donoghue D, Dean J, O'Sullivan J, O'Farrelly C, Golden-Mason L. Detection and characterization of hematopoetic stem cells in the adult human intestine. J Immunol. 2006;76:5199–5204

 Financial disclosure: See Acknowledgments on page 192.

PII: S1083-8791(08)00579-X

doi: 10.1016/j.bbmt.2008.11.031

Biology of Blood and Marrow Transplantation
Volume 15, Issue 2 , Pages 183-194 , February 2009

Article Tools

* Image Usage & Resolution